Literature DB >> 16412726

Expanding treatment options for women with symptomatic uterine leiomyomas: timely medical breakthroughs.

Gloria Bachmann1.   

Abstract

Only during the last decade has there been a flourishing of alternative treatment options to major surgery for the management of symptomatic uterine leiomyoma. In addition to currently available minimally invasive surgical interventions, such as endometrial ablation techniques, radiologic interventions with uterine artery embolization and focused ultrasound surgery are welcome treatment options, despite the lack of long-term efficacy data.

Entities:  

Mesh:

Year:  2006        PMID: 16412726     DOI: 10.1016/j.fertnstert.2005.09.010

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

1.  Comparison between diffusion-weighted imaging, T2-weighted, and postcontrast T1-weighted imaging after MR-guided, high intensity, focused ultrasound treatment of uterine leiomyomata: preliminary results.

Authors:  Michael A Jacobs; David H Gultekin; Hyun S Kim
Journal:  Med Phys       Date:  2010-09       Impact factor: 4.071

2.  1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model.

Authors:  Sunil K Halder; Chakradhari Sharan; Ayman Al-Hendy
Journal:  Biol Reprod       Date:  2012-04-19       Impact factor: 4.285

3.  Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model.

Authors:  Memy H Hassan; Salama A Salama; Dong Zhang; Hossam M M Arafa; Farid M A Hamada; Hala Fouad; Cheryl C Walker; Ayman Al-Hendy
Journal:  Fertil Steril       Date:  2009-01-14       Impact factor: 7.329

Review 4.  New and Emerging Applications of Magnetic Resonance Elastography of Other Abdominal Organs.

Authors:  Jin Wang; Ying Deng; Danielle Jondal; David M Woodrum; Yu Shi; Meng Yin; Sudhakar K Venkatesh
Journal:  Top Magn Reson Imaging       Date:  2018-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.